3Indexed trials
drug · Product Intelligence
galantamine hydrobromide
Pipeline Intelligence
galantamine hydrobromide: 3 indexed trials, 2 sponsors; 0 linked Orange Book patents and 0 FDA-linked events where matched.
2Sponsors
0Orange Book patent links
0FDA-linked events
Development evidence
NCT00216502Janssen-Cilag S.p.A. · alzheimersPHASE3
NCT00253188Johnson & Johnson Pharmaceutical Research & Development, L.L.C. · alzheimersPHASE3
NCT00253214Johnson & Johnson Pharmaceutical Research & Development, L.L.C. · alzheimersPHASE3
FDA / patent evidence
No FDA Orange Book product match is asserted for this intervention.
Regulatory context
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.